Comment & Analysis

Expectations are building about the impending release of results from Roche’s Marianne study, the ...

With four big pharma partners under its belt Incyte was the undisputed king of the hot new ...

Changes to US laws governing inversion deals have forced AbbVie to abandon its bid for Shire, and ...




Therapeutic Focus

Market Moving Events

EP Vantage Interviews